Literature DB >> 27009432

Diastereoselective Synthesis of 6″-(Z)- and 6″-(E)-Fluoro Analogues of Anti-hepatitis B Virus Agent Entecavir and Its Evaluation of the Activity and Toxicity Profile of the Diastereomers.

Hiroki Kumamoto1, Misato Fukano1, Tomohiko Nakano1, Keito Iwagami1, Chiaki Takeyama1, Satoru Kohgo2, Shuhei Imoto3, Masayuki Amano4, Nobuyo Kuwata-Higashi4, Manabu Aoki5, Hiroshi Abe6, Hiroaki Mitsuya7, Kiyoshi Fukuhara1, Kazuhiro Haraguchi8.   

Abstract

A method for the diastereoselective synthesis of 6″-(Z)- and 6″-(E)-fluorinated analogues of the anti-HBV agent entecavir has been developed. Construction of the methylenecyclopentane skeleton of the target molecules has been accomplished by radical-mediated 5-exo-dig cyclization of the selenides 6 and 15 having the phenylsulfanylethynyl structure as a radical accepting moiety. In the radical reaction of the TBS-protected precursor 6, (Z)-anti-12 was formed as a major product. On the other hand, TIPS-protected 15 gave (E)-anti-12. The sulfur-extrusive stannylation of anti-12 furnished a mixture of geometric isomers of the respective vinylstannane, whereas benzoyl-protected 17 underwent the stannylation in the manner of retention of configuration. Following XeF2-mediated fluorination, introduction of the purine base and deoxygenation of the resulting carbocyclic guanosine gave the target (E)- and (Z)-3 after deprotection. Evaluation of the anti-HBV activity of 3 revealed that fluorine-substitution at the 6″-position of entecavir gave rise to a reduction in the cytotoxicity in HepG2 cells with retention of the antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27009432      PMCID: PMC7821961          DOI: 10.1021/acs.joc.6b00105

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  11 in total

1.  Synthesis of 5'-methylenearisteromycin and its 2-fluoro derivative with potent antimalarial activity due to inhibition of the parasite S-adenosylhomocysteine hydrolase.

Authors:  Chieko Takagi; Makoto Sukeda; Hye-Sook Kim; Yusuke Wataya; Saori Yabe; Yukio Kitade; Akira Matsuda; Satoshi Shuto
Journal:  Org Biomol Chem       Date:  2005-02-28       Impact factor: 3.876

2.  (Me3Si)3SiH: twenty years after its discovery as a radical-based reducing agent.

Authors:  Chryssostomos Chatgilialoglu
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

Review 3.  Entecavir: a review of its use in chronic hepatitis B.

Authors:  Lesley J Scott; Gillian M Keating
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

Review 4.  Hepatitis B virus infection.

Authors:  Jules L Dienstag
Journal:  N Engl J Med       Date:  2008-10-02       Impact factor: 91.245

5.  Synthesis of tert-butoxycarbonyl (Boc)-protected purines.

Authors:  S Dey; P Garner
Journal:  J Org Chem       Date:  2000-11-03       Impact factor: 4.354

6.  Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

Authors:  S F Innaimo; M Seifer; G S Bisacchi; D N Standring; R Zahler; R J Colonno
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.938

Review 7.  Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

Authors:  Jiang Wang; María Sánchez-Roselló; José Luis Aceña; Carlos del Pozo; Alexander E Sorochinsky; Santos Fustero; Vadim A Soloshonok; Hong Liu
Journal:  Chem Rev       Date:  2013-12-03       Impact factor: 60.622

8.  Replication strategy of human hepatitis B virus.

Authors:  H Will; W Reiser; T Weimer; E Pfaff; M Büscher; R Sprengel; R Cattaneo; H Schaller
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Sulfur extrusion with tin radical: synthesis of 4',5'-didehydro-5'-deoxy-5'-(tributylstannyl)adenosine, an intermediate for potential inhibitors against S-adenosyl homocysteine hydrolase.

Authors:  Hiroki Kumamoto; Sayoko Onuma; Hiromichi Tanaka
Journal:  J Org Chem       Date:  2004-01-09       Impact factor: 4.354

10.  Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus.

Authors:  G Yamanaka; T Wilson; S Innaimo; G S Bisacchi; P Egli; J K Rinehart; R Zahler; R J Colonno
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.938

View more
  2 in total

1.  Synthesis and evaluation of the anti-hepatitis B virus activity of 4'-Azido-thymidine analogs and 4'-Azido-2'-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent.

Authors:  Kengo Onitsuka; Ryoh Tokuda; Nobuyo Kuwata-Higashi; Hiroki Kumamoto; Manabu Aoki; Masayuki Amano; Satoru Kohgo; Debananda Das; Kazuhiro Haraguchi; Hiroaki Mitsuya; Shuhei Imoto
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2019-09-12       Impact factor: 1.381

2.  Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors:  Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2017-09-28       Impact factor: 15.419

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.